BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioAxone Therapeutic Inc. 

Université de Montreal

Montreal      Canada
Phone: 514-990-1074 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Start Up





 Company News
ALSERES Pharmaceuticals, Inc. (ALSE) and BioAxone Therapeutic Inc. Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology 4/30/2009 10:46:19 AM    More...
BioAxone Therapeutic Inc. Licenses Phase II Spinal Cord Injury Drug Cethrin(R) To Boston Life Sciences (BLSI) 1/4/2007 11:58:50 AM    More...
BioAxone Therapeutic Inc. Study Demonstrates Positive Interim Results For Spinal Cord Injury 11/27/2006 10:06:57 AM    More...
BioAxone Therapeutic Inc. Announces Patients Completed The 6 Week Follow-Up In The Phase I/IIa Trial Of Cethrin(R) For The Treatment Of Acute Spinal Cord Injury 9/19/2006 2:20:20 PM    More...
BioAxone Therapeutic Inc. Completes Patient Enrollment For Phase I/IIa Trial Of Cethrin(R) In Treatment Of Acute Spinal Cord Injury 7/10/2006 10:35:51 AM    More...
BioAxone Therapeutic Inc. Announces Closing Of $5.1 Million 12/19/2005 10:26:22 AM    More...
BioAxone Therapeutic Inc. Release: Cethrin(R) Receives Orphan Drug Status 12/12/2005 12:09:25 PM    More...
BioAxone Therapeutic Inc. Appoints Patrick Tremblay Vice President Research & Development 11/29/2005 10:44:39 AM    More...
BioAxone Therapeutic Inc. Announces First Patient Treatment In Acute Spinal Cord Injury Trial 10/19/2005 5:12:38 PM    More...
BioAxone Therapeutic Inc. Announces A Second-Round Investment Of $12.15 Million 10/19/2005 5:09:54 PM    More...